Endoscopy Market Size & Share 2025 - 2034

Endoscopy Market Size

The global endoscopy market was valued at USD 29.5 billion in 2024. The market is expected to reach from USD 31.2 billion in 2025 to USD 56.9 billion in 2034, growing at a CAGR of 6.9% during the forecast period.
 

The high market growth is attributed to the rising prevalence of chronic and gastrointestinal diseases, technological advancements in endoscopic devices, growing preference for minimally invasive surgeries (MIS), and aging population and increased healthcare utilization, among other contributing factors.
 

The prevalence of chronic illnesses such as gastrointestinal disorders, colorectal cancer, and cardiovascular diseases is rising globally. For instance, according to the World Health Organization (WHO), cardiovascular diseases accounted for 20.5 million deaths in the year 2021, which is 32% of the total deaths. Similarly, the American Cancer Society estimates around 106,970 new cases of colon cancer and 46,050 new cases of rectal cancer in 2023. In addition, as per the data by CDC, about 22.4 million adults were reported for gastrointestinal disorders in the year 2022. Endoscopy is a pivotal diagnostic and therapeutic procedure for the above problems. The escalating prevalence of such diseases increases the necessity for cost effective procedures to treat and diagnose such conditions, especially for cancer.
 

Furthermore, healthcare systems are being developed and improved as governments and private corporations increase their spending. For instance, the U.S. allocated USD 8.5 billion in its 2021 Infrastructure Investment and Jobs Act for the modernization of healthcare facilities in rural areas. These investments seek to purchase contemporary medical equipment, such as endoscopic systems. On top of that, the World Bank granted USD 1.2 billion in 2022 towards training for healthcare practitioners in developing countries, a large part of which is for training of endoscopic procedures.
 

Endoscopy is a medical process performed by the doctor using an endoscope, a lighted flexible tube fitted with a camera at the tip to observe the internal parts of a patient's body. It enables the physician to view and assess various structures which include lungs, joints and the gastrointestinal tract without making anywhere near as large of an incision as traditional surgery. Typical uses of endoscopy include performing diagnoses, surgical biopsies, and some treatment procedures.
 

Endoscopy Market Trends

The market is currently experiencing increased growth owing to the innovations in the design of endoscopes, rise in single-use endoscope procedures, the growth of robotic-assisted endoscopy, rising integrated artificial intelligence in healthcare, among other factors are boosting the industry growth.
 

• The growing concern regarding cross-contamination and hospital-acquired infections (HAIs) has stimulated the demand for single-use endoscopes. Due to the lack of sterilizing procedures that reusable scopes need; these single use scopes eliminate the threat of operational infections. They are picking up popularity in bronchoscopy and urology. Single use endoscope production at an affordable price and is dominated by companies like Ambu and Boston Scientific. Such a trend aids in the management of infections, especially during COVID-19 and in outpatient clinics.
   
• In recent years, capsule endoscopes with built-in cameras have become essential in the diagnosis of small bowel issues such as Crohn's disease, obscure bleeding and neoplasms. For patients, this approach is far more pleasant than traditional methods. Efficiency and accuracy of this technology is enhanced through advancements such as AI powered real time data transfer and processing. Standard endoscopy procedures are not perfect option available to all patients, and this is where capsule endoscopy technology is especially beneficial.
   
• In addition, endoscopy is used not only for examination but also for treatment methods such as stent and polyp insertion, and even tumor resections. Its therapeutic usage is being enhanced with the use of new technologies such as energy devices, endoscopic suturing, and endoscopic ultrasound (EUS). The innovation of hybrid systems that integrate diagnostic and therapeutic components is enhancing the quality of patient care. These new devices are making endoscopy an instrumental method for minimal surgical intervention procedures, which in turn increases the market demand.
   

Endoscopy Market Analysis

Based on product, the market is classified into endoscopes, visualization systems, endoscopic ultrasound, insufflator, and other products. The endoscopes segment generated the highest revenue of USD 14.5 billion in 2024.
 

• New developments in medicine, such as the improvements in imaging like high-definition (HD) imaging or 3D visualization and the incorporation of Narrow-band imaging (NBI) within endoscopic procedures, have greatly improved the accuracy achieved by endoscopes. The efficiency and accuracy of the procedures are also improved by adding other features like wireless communication, robotics, and AI (Artificial Intelligence).
   
• Furthermore, the design of the endoscope itself has made it more useful through the incorporation of miniature, lightweight, and flexible features, which allow access to previously unreachable locations. It is for these reasons that specialists from gastroenterologists to pulmonologists consider endoscopes an essential device.
   
• Additionally, single use and clinical devices have gained importance and usage in modern medicine because they reduce costs associated with reprocessing, sterilization, and most importantly, the chance of infections.
   
• These devices help mitigate the risk of cross-infection and HAIs, which is very critical during pandemics. In bronchoscopy and in urology, single use endoscopes offer the greatest benefits. They are progressively valued for their effectiveness, safety, and cost effectiveness to outpatient’s practitioners.
   
• Moreover, the global burden of cancer, especially gastrointestinal and colorectal cancers, has surged the demand for endoscopy procedures as a means of early detection. The WHO predicts that there will be 30 million new cancer cases by 2024 and that gastrointestinal cancers will account for 26% of cancer deaths worldwide in 2022.
   
• Endoscopes are essential in conducting biopsies, tumor resections, and performing other minimally invasive procedures that monitor the condition, which helps enhance patient survival. This will likely spur substantial gains in this segment of the market.
   

Based on application, the endoscopy market is classified into laparoscopy, GI endoscopy, arthroscopy, ENT endoscopy, pulmonary endoscopy, obstetrics/gynecology, and other applications. The laparoscopy segment accounted for USD 5.4 billion in market revenue in 2024 and is anticipated to grow at a CAGR of 6.5% between the 2025 to 2034 period.
 

• The use of laparoscopy is increasing as it is less painful and has a faster recovery time when compared to traditional surgery. Due to the recently discovered benefits of keyhole surgery, many patients are opting for it, making gallbladder removal and hernia repairs much easier.
   
• Increasing awareness about the advantages of keyhole surgery is pushing forward the demand for the relevant devices and technology, which in turn grows the market. This benefits both patients and healthcare professionals, as they prefer these new procedures. Additionally, with a few small cuts, surgeons can now perform more procedures, provided the patient has a condition that requires surgery.
   
• Further, there is a surge in people opting for bariatric surgeries due to the increase in obesity. According to the WHO, over 1 billion individuals were considered obese in 2022. In 2021, America executed about 198,000 surgeries, with a spike of 32.5% in the following year. The preferred approach for gastric bypass and sleeve gastrectomy surgeries is laparoscopy, and the greater desire for more effective weight-loss strategies indicates further expansion of the market.
   
• Moreover, the growing acceptance of laparoscopic operations has also expanded the range of training and teachings within this field. Today, workshops, simulations, and hands-on training are provided to the surgeons for learning laparoscopic skills. The suppliers of the laparoscopic instruments are collaborating with the medical schools to design appropriate learning modules for the application of these instruments.
   
• With an increased number of trained practitioners, there is a greater understanding of the benefits of these procedures, thus the frequency and adoption of laparoscopic surgeries is steadily increasing around the globe. All of these factors would support the segmental growth of the market.
   

Based on end use, the market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market in 2024 and is anticipated to reach USD 34.8 billion by the end of the forecast period.

• Hospitals are increasingly valued endoscopy for standard screenings and early detection of diseases, especially for certain types of cancers like colorectal cancer. Patients undergoing endoscopic procedures are often diagnosed at an earlier stage. This results in their treatment being more effective, leading to better health outcomes and less burden on the health system in the long run. With a greater focus on preventive health, hospitals are enhancing their endoscopic capabilities to address the growing demand for such screenings and early diagnosis procedures.
   
• Additionally, government policies and insurance coverage for an array of endoscopic procedures, like cancer screenings, are broadening the number of patients who can benefit from these services. Increased reimbursement rates for these hospitals encourage them to acquire and maintain costly endoscopic devices. Hospitals are more willing to improve their endoscopic capabilities because these reimbursement policies appear to be more favorable. Furthermore, hospitals have been able to offset some of the costs related to servicing and procuring those devices.
   
• In addition, there is an expectation that hospitals will reduce their costs while improving the quality of the services that they provide. Endoscopic procedures, which are minimally invasive and require less hospitalization and recovery time, help hospitals achieve these cost-saving goals. To meet the demand for high-quality and affordable services, endoscopy has become an essential part of providing effective healthcare.
   
• Further, these centers are spending resources on training and certification programs to keep healthcare professionals abreast of the latest endoscopic technologies.  The advancements in endoscope technology are significant, so it is important for medical staff to stay informed. Having more skilled professionals in endoscopic procedures improves hospitals' ability to serve patients, which supports growth in this segment.
   

U.S. endoscopy market was valued at USD 9.2 billion and USD 9.5 billion in 2021 and 2022, respectively. The market size reached USD 10.4 billion in 2024, growing from USD 9.9 billion in 2023 and is anticipated to grow at a CAGR of 6.1% between the 2025 to 2034 period.
 

• The U.S. has a high demand for endoscopy instruments owing to the growing chronic illnesses such as colorectal cancer, obesity, and gastrointestinal conditions needing endoscopic surgeries. The American Cancer Society predicts about 153,000 cases of colorectal cancer in the country in 2024. Moreover, roughly 52,550 people are anticipated to die from colorectal cancer disease.
   
• Also, the National Health and Nutrition Examination Survey out in 2022, reports that roughly 41.9% of adults aged 20 and above are obese. Such statistics are likely to worsen chronic gastrointestinal illnesses that will need endoscopic surgeries. It is evident that the growing need to identify and monitor diseases is driving the demand for endoscopic instruments, devices, and procedures.
   
• The country has one of the best healthcare systems in the world, which is complemented by fully-fledged hospitals, outpatient facilities, and research institutes. The new systems for endoscopy with robotic arms and AI-powered endoscopes can be utilized alongside the advanced medical systems that are already in place. These technologies play a key role in improving the use of endoscopy for diagnosis and treatment, which helps in advancing the entire market.
   
• The reimbursement policies of the U.S. healthcare system further encourage patient access, as they favor the reimbursement of endoscopic surgeries.  Patients do not have to worry so much about the costs because their economic burden is alleviated by the reimbursements from Medicare, Medicaid, and Private Health Insurance companies for any diagnostic and/or treatment procedures performed, including colonoscopy or endoscopic ultrasounds. This increases the likelihood of patients and healthcare providers adopting endoscopic procedures.
   

Europe endoscopy market accounted for USD 7.7 billion in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The integration of the public and private sectors within the European healthcare system is quite remarkable. Most European nations offer universal healthcare, which makes a range of diagnostic procedures, like endoscopy, readily available to the public. As reported by Eurostat, the EU healthcare expenditure rose to roughly 11% of GDP in 2022, with Germany (12.7%) and France (12.2%) as the primary spenders.
   
• The region’s hospitals and specialty clinics have sophisticated diagnostic equipment for early disease detection and treatment. For the EU4Health program (2021-2027), the European Commission invested about USD 6 billion, with an estimated USD 831.3 million directed toward diagnostic equipment in 2023. This infrastructure is vital for organized screening programs, especially for gastrointestinal diseases and various cancers.
   
• In 2023, the European Health Data Space initiative received funding of USD 916.2 million which was aimed at enhancing the digital health infrastructure. This funding, along with the previously mentioned public health expenditures, increases the demand for advanced diagnostic tools. Public health expenditure across EU-27 nations saw a 4.2% increase in 2023, Endoscopy and medical imaging equipment remain in steady demand throughout the region.
   

Germany endoscopy market is projected to grow remarkably in the coming years.
 

• Germany has one of the best healthcare systems in Europe with advanced medical devices and equipment. The presence of sophisticated endoscopy tools in hospitals and outpatient clinics guarantees high adoption of endoscopic procedures. The developed infrastructure of the nation makes it easier to incorporate new endoscopy technologies in primary healthcare activities.
   
• The focus on shorter postoperative recovering period, lesser complications, and better healthcare outcomes has led more patients and providers to prefer advanced endoscopic surgeries over other procedures. Endoscopic methods are on the rise for diagnostic and therapeutic purposes in both gastroenterology and urology. This trend is encouraging more hospitals and clinics to upgrade to higher-quality endoscopic equipment.
   
• In addition, there are funds targeted toward the enhancement of medical technologies, including endoscopy, which are incorporated into the healthcare system in Germany. Patients benefit from favorable reimbursement policies that make advanced endoscopic procedures more affordable. Programs offered by the government also promote early detection and treatment of medical conditions, resulting in increased number of screenings and procedures such as gastroscopies and colonoscopies.
   
• Additionally, the country is a leader in the using artificial intelligence and machine learning to endoscopic systems. Tools driven by AI can perform much better in detecting abnormalities such as polyps or tumors, reducing the chances of missed diagnoses. The growing acceptance of such AI-powered endoscopic solutions is improving the results of procedures and boosting market expansion.
   

The Asia Pacific endoscopy market is anticipated to grow at the highest CAGR of 7.7% during the analysis timeframe.
 

• Countries like China, India, and Southeast Asian nations are investing heavily in expanding healthcare facilities and services. New hospitals, diagnostic centers, and surgical units are being established to meet rising healthcare demands.
   
• This growth is driven by public and private sector investment in new sophisticated diagnostic equipment, including endoscopic devices. The expansion also covers urban areas and tier-2 cities. It increases the demand for both therapeutic and diagnostic endoscopic devices.
   
• The Asia-Pacific region is facing an upsurge in gastrointestinal disorders, liver diseases, colorectal cancers, and obesity. Increased consumption of unhealthy foods and alcohol, and a decrease in physical activity all exacerbate these conditions.
   
• Endoscopy allows for early intervention which is essential in the prevention and management of these diseases. There has been an increase in participation due to the campaigns. There is a considerable population in APAC countries which enables consistent procedure volumes across hospitals and outpatient clinics.
   

Japan holds a dominant position in the Asia Pacific endoscopy market.
 

• Japan is among the best in the world when it comes to medical technology. The country is home to leading players in the market. Olympus, Fujifilm, and HOYA are majorly focusing on developing innovative endoscopic devices. The adoption of new technologies has been greatly enhanced by Japanese proprietary systems, which include artificial intelligence, high-definition imaging, and narrow-band imaging. These systems have significantly improved the quality of diagnosis and operations.
   
• Additionally, Japanese people aged 65 and above accounted for roughly 30% of the population in 2023, as per the estimates provided by the Ministry of Internal Affairs and Communications. The Statistics Bureau Japan also noted a rise from 29.1% in 2021 to 29.8% in 2022, with projections estimating a rise to 31.2% by 2024.
   
• On top of that, chronic illnesses are more common in the aged population. According to the Ministry of Health, Labour, and Welfare, the number of patients above the age of 65 suffering from gastrointestinal issues increased by 8.5% in 2022 in comparison to the previous year.
   
• The increasing number of elderly populations continues to contribute to the growth of the Japanese endoscopy industry, as more healthcare providers offer services to meet the increasing demand.
   

The Brazil endoscopy market is experiencing robust growth in Latin America market.
 

• Brazil’s Ministry of Health Ministry has launched specific national programs aimed at improving the early detection of several cancers, including colorectal and gastric cancers. To address this, public hospitals are making strides in providing greater access to endoscopic services.
   
• Programs such as SUS (Unified Health System) strive to combat mortality from cancer by offering more comprehensive diagnostic services. Additionally, public-private partnerships are aiding in bridging the gap in available equipment. This heightened focus on preventative measures buttresses the sustained demand for endoscopic diagnostics.
   
• Increased urbanization is causing faster adoption of sedentary lifestyles among the Brazilian population which, in turn, is causing an increase in obesity, diabetes, and other digestive disorders. There is also an increase in GERD, fatty liver, and colorectal diseases.
   
• These changes in the pattern of illnesses increase the need for GI endoscopy in urban hospitals and in outpatient centers. There is also an increased focus by health leaders on managing chronic diseases of lifestyle which increases the utilization of endoscopic screening and treatment.
   

Saudi Arabia endoscopy market is poised to witness substantial growth in Middle East and Africa market during the forecast period.
 

• Saudi Arabia’s Vision 2030 initiative emphasizes diversifying the economy and transforming the healthcare sector through privatization and modernization. The government is investing heavily in infrastructure, diagnostics, and minimally invasive technologies, including endoscopy.
   
• Public hospitals are being refurbished, and new medical cities are being constructed. This effort is increasing the availability of specialized care as well as driving the purchase of endoscopic systems. The policy supports international market medtech sponsors entering the region.
   
• Moreover, the country is collaborating more with foreign institutions for healthcare and devices to educate local physicians and technicians advanced endoscopic techniques. These collaborations strengthen and enhance system-wide capacity building and skill development.
   
• As more Saudi professionals become trained in endoscopy, adoption rates and procedural volumes are increasing. Educational programs and workshops also promote the best practices and standardization of care. This boosts confidence in the use of endoscopic technologies nationwide.
   

Endoscopy Market Share

The market is experiencing steady growth, driven by continuous innovation, increased investments, and strategic collaborations among leading industry players. Major companies such as Olympus Corporation, Stryker Corporation, Karl Storz, Boston Scientific, and Medtronic collectively hold approximately 42%–45% of the market share. These key players maintain strong market dominance by offering advanced endoscopic systems and accessories.
 

Many are actively developing next-generation technologies, including AI-integrated endoscopy, robotic-assisted procedures, and holographic imaging, to enhance diagnostic accuracy and patient outcomes. Additionally, through mergers, acquisitions, and strategic partnerships, these companies are expanding their global footprint, diversifying product portfolios, and strengthening their competitive edge in this rapidly evolving market.
 

Endoscopy Market Companies

Prominent players operating in the endoscopy industry include:

• B Braun
• Boston Scientific
• CONMED
• COOK MEDICAL
• FUJIFILM
• HOYA
• INTUITIVE
• Johnson & Johnson
• KARL STORZ
• Medtronic
• OLYMPUS
• RICHARD WOLF
• Smith & Nephew
• Stryker

 

• Olympus dominates the market by utilizing modern imaging technologies such as 4K Ultra HD and Narrow Band Imaging (NBI), which enhance diagnostics further. Their trust as a global leader comes from their wide range of endoscopic tools combined with their focus on innovation.
   
• Karl Storz focuses on the development of premium endoscopic instruments and aids for rigid and flexible endoscopy procedures. Niche-specialized, precise, and robust engineering underline a certain level of flexibility and usage in numerous medical specialties.
   

Endoscopy Industry News

• In April 2024, Ambu obtained 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its next-generation duodenoscopy solution, the aScope Duodeno 2 and aBox 2, designed for endoscopic retrograde cholangiopancreatography (ERCP) procedures. This approval is expected to enhance the company’s product range, enable a broader customer base and strengthen its market positioning.
   
• In April 2022, Laborie Medical Technologies Corp.announced that it has completed the acquisition of GI Supply, a leader in specialty endoscopy and paracentesis products for gastroenterologists, colorectal surgeons, and interventional radiologists. This acquisition enabled the company to expand its product portfolio and enabled a bigger customer base.
   
• In December 2021, Smith+Nephew partnered with Flex, a manufacturing solutions provider, to successfully implement the Marketing Authorization Holder (MAH) policy for medical devices in Shanghai. This partnership enabled the local production of Smith+Nephew's endoscopic camera systems, which are used in orthopedic endoscopic surgeries, and generated high revenue.
   

The endoscopy market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Market, By Product

• Endoscopes
  • Rigid endoscopes
  • Flexible endoscopes
  • Capsule endoscopes 
• Visualization systems
• Endoscopic ultrasound
• Insufflator
• Other products

Market, By Application

• Laparoscopy
• GI endoscopy
  • Gastroscopy
  • Colonoscopy
  • Sigmoidoscopy
  • Duodenoscopy
  • Other GI endoscopies 
• Arthroscopy
• ENT endoscopy
• Pulmonary endoscopy
• Obstetrics/Gynecology
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE